CD44 and breast cancer: Of note, GSEA indicates that OST-01 treatment promotes a shift in TNBC and triple-positive BC cells from a basal-mesenchymal to a luminal-epithelial state, with reduced CD44 and increased CD24 expression in MDA-MB-231 cells (Fig. 2H-J and Sup.